HOME > Product > SKAD
New salt form of amlodipine comparable to amlodipine besylate
FDA approved amlodipine salt
Well-tolerated antihypertensive and antianginal agent

Each tablet contains 6.42mg of amlodipine maleate (5mg as amlodipine)


Hypertension, chronic stable angina, vasospasmodic angina (Prinzmetal's or variant angina)

Adults: The usual initial oral dose of SKAD is 5 mg as amlodipine once daily with a maximum dose of 10 mg once daily. The dosage may be adjusted according to age or symptoms of the patient.


1. SKAD is a long-acting calcium channel blocker that dilates peripheral arteries to cause a reduction in peripheral vascular resistance.
2. SKAD has been confirmed to be therapeutically equivalent to amlodipine besylate in the treatment of mild to moderate hypertension by a comparative phase III clinical study.
3. Due to its high efficacy and safety, it is guaranteed to be well tolerated over a long-term treatment.
4. It is a pharmaco-economic amlodipine because it is only 80% of the cost of amlodipine besylate.